Inviragen, Inc.
Biotechnology company · Fort Collins, Colorado, United States
Inviragen, Inc. is a biotechnology company headquartered in Fort Collins, Colorado, United States. Its earliest recorded incorporation is in 2006. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $5.2 million in total, most recently in 2009. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2012.
Inviragen at a glance
What does Inviragen do?
US government research funding
6 SBIR/STTR small-business research awards from US health agencies, $5.2 million in total (2006 to 2009).
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $15.3 million sold (2012).
Frequently asked questions about Inviragen
Where is Inviragen headquartered?
Inviragen, Inc. is headquartered in Fort Collins, Colorado, United States.
What does Inviragen do?
Inviragen, Inc. is a biotechnology company.
When was Inviragen founded?
The earliest incorporation on record for Inviragen, Inc. is in 2006, according to public company registers.
Similar companies
- SiVEC Biotechnologies, Inc.Fort Collins, Colorado, United States
- PhotonPharma, Inc.Fort Collins, Colorado, United States
- Omni Bio Pharmaceutical, Inc.Fort Collins, Colorado, United States
- Cytocom Inc.Fort Collins, Colorado, United States
- Cetya Therapeutics, Inc.Fort Collins, Colorado, United States
- Solaris Vaccines, Inc.Fort Collins, Colorado, United States
- Symbios Technologies Inc.Fort Collins, Colorado, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences